Trials / Completed
CompletedNCT04452266
Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome
Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome: Study Conducted in the Hauts-de-France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
Lynch Syndrome increases Endometrial Cancer Occurrence in women due to failure in MisMatch Repair System. Lifetime Cumulative risk of developing endometrial Cancer is approximatively 40% in women with Lynch Syndrome. Endometrial cancer is the third women cancer in France. Many risk factors are known in general population. Lots of factors are related to over exposure to estrogen. Data about influence of general risk factors in Women with Lynch Syndrome are poor. Recently, a cohort study appears to have shown a significant decrease in the risk of endometrial cancer with multiparity, the use of hormonal contraception and late menopause in Lynch women. The impact of weight and certain metabolic parameters on the occurrence of endometrial cancers remains poorly known to this day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire assesment | Each patient will to answer questions about their medical history. |
Timeline
- Start date
- 2020-08-14
- Primary completion
- 2020-10-20
- Completion
- 2020-10-20
- First posted
- 2020-06-30
- Last updated
- 2021-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04452266. Inclusion in this directory is not an endorsement.